Approximately 66 per cent of individuals in India are exposed to...
Category:
Disaster & Management
Latest
Raging Yamuna swells to record level in Delhi
New Delhi: The Yamuna in Delhi swelled to 207.55 metres on...
Rain-battered north India counts its losses, rescue efforts gather pace
Northwest India saw incessant rainfall during the last three days,...
After rush to exit India in March & Apr, FPIs invest Rs 9k cr in May so far
“Attractive valuation after the sharp correction in the equity markets this year, and significant depreciation of Indian rupee against USD provided FPIs a good entry point,” saidHimanshu Srivastava, Senior Analyst Manager Research, Morningstar India.
Record 6,767 new COVID-19 cases in India in last 24 hours; death toll climbs to 3,867
Of the 147 deaths reported since Saturday morning, 60 were in Maharashtra, 27 in Gujarat, 23 in Delhi, nine in Madhya Pradesh, seven in Rajasthan, five in Tamil Nadu, four each in West Bengal and Telangana, three in Uttar Pradesh, and one each in Andhra Pradesh, Jammu and Kashmir, Karnataka, Uttarakhand and Jharkhand
Coronavirus patients not infectious after 11, say experts
A positive test “does not equate to infectiousness or viable virus,” a joint research paper by Singapore’s National Centre for Infectious Diseases and the Academy of Medicine, Singapore said. The virus “could not be isolated or cultured after day 11 of illness.”
Major Indian states seek delay in restarting flights as coronavirus cases rise
Airlines are preparing to resume about a third of their domestic flight operations from Monday, even without clarity over which states will allow flights or what quarantine rules may apply to passengers.
India’s western state of Maharashtra, Tamil Nadu in the south and West Bengal in the east, major business hubs and home to the country’s busiest airports, have said they are not prepared to open for flights amid rising coronavirus cases, according to state government officials.
ICMR’s new advisory expands use of HCQ but cautions against false security
The revised advisory issued by the Indian Council of Medical Research (ICMR) has recommended the use of hydroxychloroquine as a preventive medication for asymptomatic healthcare professionals working in non-Covid-19 hospitals, frontline staff on surveillance duty in containment zones and paramilitary/police personnel involved in coronavirus infection related activities.
Guidelines for international arrivals issued; 14-day quarantine compulsory
Only for exceptional and compelling reasons such as cases of human distress, pregnancy, death in family, serious illness and parent(s) accompanied by children below 10 years, as assessed by the receiving states, home quarantine may be permitted for 14 days, they said.
Use of Aarogya Setu application shall be mandatory in such cases, the guidelines said.
UK’s Aviva expects COVID-19-related claims of nearly $200 Million
Aviva said on Thursday the “vast majority” of its commercial policies did not cover business interruption claims arising from COVID-19, but it had paid some claims in Britain and Canada where cover was in place.
UK insurers,banks prepare for return to office of the future
And while the 330-year-old Lloyds of London insurance market does not plan to reopen its underwriting floor before August, 40-50 “pathfinders” may start returning from June, its Chief Executive John Neal said.
Spike in cyber crimes amidst lockdown: Maha home minister
He said that there has been “a big rise” in crimes like spreading provocative content, rumours and objectionable posts against women and creating communal divide using social media platforms like WhatsApp, Facebook, Twitter, Instagram and TikTok.
First COVID-19 vaccine human trial finds it is safe, induces immune response
However, the scientists, including those from the Beijing Institute of Biotechnology in China said further research is needed to confirm whether the vaccine protects against SARS-COV-2 infection.
“These results represent an important milestone. The trial demonstrates that a single dose of the new adenovirus type 5 vectored COVID-19 (Ad5-nCoV) vaccine produces virus-specific antibodies and T cells in 14 days,” said study co-author Wei Chen from the Beijing Institute of Biotechnology.